972 reports of this reaction
1.3% of all APREPITANT reports
#15 most reported adverse reaction
INFUSION RELATED REACTION is the #15 most commonly reported adverse reaction for APREPITANT, manufactured by Merck Sharp & Dohme LLC. There are 972 FDA adverse event reports linking APREPITANT to INFUSION RELATED REACTION. This represents approximately 1.3% of all 73,587 adverse event reports for this drug.
Patients taking APREPITANT who experience infusion related reaction should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
INFUSION RELATED REACTION is a less commonly reported adverse event for APREPITANT, but still significant enough to appear in the safety profile.
In addition to infusion related reaction, the following adverse reactions have been reported for APREPITANT:
The following drugs have also been linked to infusion related reaction in FDA adverse event reports:
INFUSION RELATED REACTION has been reported as an adverse event in 972 FDA reports for APREPITANT. This does not prove causation, but indicates an association observed in post-market surveillance data.
INFUSION RELATED REACTION accounts for approximately 1.3% of all adverse event reports for APREPITANT, making it a notable side effect.
If you experience infusion related reaction while taking APREPITANT, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.